Resolution of chylous pulmonary congestion and respiratory failure in lymphangioleiomyomatosis with sirolimus therapy

American Journal of Respiratory and Critical Care Medicine

Volumn 186, Issue 4, 2012, Pages 389-390

  Moua, Teng ^a   Olson, Eric J ^a   St Jean, Hope C ^a   Ryu, Jay H ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN;

ADULT; CASE REPORT; CHYLOTHORAX; CHYLOUS LUNG CONGESTION; COMPUTER ASSISTED TOMOGRAPHY; DYSPNEA; ECHOGRAPHY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN TISSUE; LETTER; LUNG BIOPSY; LUNG CONGESTION; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; LYMPHANGIOLEIOMYOMATOSIS; OXYGEN THERAPY; PLEURODESIS; PRIORITY JOURNAL; RESPIRATORY FAILURE; THORACOCENTESIS; THORACOSCOPY; THORAX RADIOGRAPHY;

CHYLE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHANGIOLEIOMYOMATOSIS; MIDDLE AGED; RESPIRATORY INSUFFICIENCY; SIROLIMUS;

EID: 84865285609     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/ajrccm.186.4.389     Document Type: Letter

References (19)

1. Zhang X, Travis WD. Pulmonary lymphangioleiomyomatosis. Arch Pathol Lab Med 2010;134:1823-1828.
2. Ryu JH, Moss J, Beck GJ, Lee J-C, Brown KK, Chapman JT, Finlay GA, Olson EJ, Ruoss SJ, Maurer JR, et al. The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. Am J Respir Crit Care Med 2006;173:105-111.
3. Johnson SR, Cordier JF, Lazor R, Cottin V, Costabel U, Harari S, Reynaud-Gaubert M, Boehler A, Brauner M, Popper H, et al. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J 2010;35: 14-26.
4. Hohman DW, Noghrehkar D, Ratnayake S. Lymphangioleiomyomatosis: a review. Eur J Intern Med 2008;19:319-324.
5. Almoosa KF, McCormack FX, Sahn SA. Pleural disease in lymphangioleiomyomatosis. Clin Chest Med 2006;27:355-368.
6. Ryu JH, Doerr CH, Fisher SD, Olson EJ, Sahn SA. Chylothorax in lymphangioleiomyomatosis. Chest 2003;123:623-627.
7. Yu J, Parkhitko AA, Henske EP. Mammalian target of rapamycin signaling and autophagy: roles in lymphangioleiomyomatosis therapy. Proc Am Thorac Soc 2010;7:48-53.
8. Darling TN, Pacheco-Rodriguez G, Gorio A, Lesma E, Walker C, Moss J. Lymphangioleiomyomatosis and TSC2-/- cells. Lymphat Res Biol 2010;8:59-69.
9. McCormack F, Inoue Y, Moss J, Singer LG, Strange C, Nakata K, Barker AF, Chapman JT, Brantly ML, Stocks JM, et al. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med 2011; 364:1595-1606.
10. Taveira-DaSilva AM, Hathaway O, Stylianou M, Moss J. Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus. Ann Intern Med 2011;154: 797-805.
11. Glasgow CG, Taveira-Dasilva AM, Darling TN, Moss J. Lymphatic involvement in lymphangioleiomyomatosis. Ann N Y Acad Sci 2008; 1131:206-214.
12. Seyama K, Kumasaka T, Kurihara M, Mitani K, Sato T. Lymphangioleiomyomatosis: a disease involving the lymphatic system. Lymphat Res Biol 2010;8:21-31.
13. Cornog JL Jr, Enterline HT. Lymphangiomyoma, a benign lesion of chyliferous lymphatics synonymous with lymphangiopericytoma. Cancer 1966;19:1909-1930.
14. Miller WT, Cornog JL Jr, Sullivan MA. Lymphangiomyomatosis. A clinical-roentgenologic-pathologic syndrome. Am J Roentgenol Radium Ther Nucl Med 1971;111:565-572.
15. Wolff M. Lymphangiomyoma: clinicopathologic study and ultrastructural confirmation of its histogenesis. Cancer 1973;31:988-1007.
16. Silverstein EF, Ellis K, Wolff M, Jaretzki A III. Pulmonary lymphangiomyomatosis. Am J Roentgenol Radium Ther Nucl Med 1974;120:832-850.
17. Stovin PG, Lum LC, Flower CD, Darke CS, Beeley M. The lungs in lymphangiomyomatosis and in tuberous sclerosis. Thorax 1975;30: 497-509.
18. Corrin B, Liebow AA, Friedman PJ. Pulmonary lymphangiomyomatosis. A review. Am J Pathol 1975;79:348-382.
19. Henske E. Tuberous sclerosis complex and lymphangioleiomyomatosis: miles to go, promises to keep. Ann Intern Med 2011;154:840-841.